{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T00:03:10Z","timestamp":1758412990497,"version":"3.44.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA120228"],"award-info":[{"award-number":["R01CA120228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003482","name":"John Wayne Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003482","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jss.2022.06.031","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T07:18:58Z","timestamp":1659683938000},"page":"682-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Four Immune Modulating Genes in Primary Melanoma That Predict Metastatic Potential"],"prefix":"10.1016","volume":"279","author":[{"given":"Jennifer","family":"Erdrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-5918","authenticated-orcid":false,"given":"Kristel","family":"Lourdault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-831X","authenticated-orcid":false,"given":"Alex","family":"Judd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Gainsbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0914-7220","authenticated-orcid":false,"given":"Nan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4852-4896","authenticated-orcid":false,"given":"Wonwoo","family":"Shon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2146-8417","authenticated-orcid":false,"given":"Richard","family":"Essner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2022.06.031_bib1","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: National cancer statistics","volume":"126","author":"Henley","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2022.06.031_bib2","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jss.2022.06.031_bib3","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2022.06.031_bib4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma","volume":"381","author":"Robert","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2022.06.031_bib5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jss.2022.06.031_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jnci\/djaa012","article-title":"Clinicopathological features, staging, and current approaches to treatment in high-risk resectable melanoma","volume":"112","author":"Keung","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jss.2022.06.031_bib7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/sj.bjc.6605055","article-title":"CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion","volume":"100","author":"Singh","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jss.2022.06.031_bib8","doi-asserted-by":"crossref","first-page":"33123","DOI":"10.1038\/srep33123","article-title":"Chemokine CXCL1 mediated neutrophil recruitment: role of glycosaminoglycan interactions","volume":"6","author":"Sawant","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jss.2022.06.031_bib9","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/bjd.14727","article-title":"An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel","volume":"175","author":"Thurneysen","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jss.2022.06.031_bib10","first-page":"4867","article-title":"Circulating levels of VEGF and CXCL1 are predictive of metastatic organotropismin in patients with colorectal cancer","volume":"37","author":"Divella","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jss.2022.06.031_bib11","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1080\/15384047.2019.1647056","article-title":"Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis","volume":"20","author":"Zhang","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jss.2022.06.031_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0022-202X.2005.23820.x","article-title":"Endothelin-1 induces CXCL1 and CXCL8 secretion in human melanoma cells","volume":"125","author":"Mangahas","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jss.2022.06.031_bib13","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/j.1460-2075.1988.tb03042.x","article-title":"Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin","volume":"7","author":"Richmond","year":"1988","journal-title":"EMBO J"},{"issue":"12 Pt 1","key":"10.1016\/j.jss.2022.06.031_bib14","first-page":"6390","article-title":"Characterization of autostimulatory and transforming growth factors from human melanoma cells","volume":"45","author":"Richmond","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2022.06.031_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jcp.1041290316","article-title":"Purification of melanoma growth stimulatory activity","volume":"129","author":"Richmond","year":"1986","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jss.2022.06.031_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jcb.240340304","article-title":"Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells","volume":"34","author":"Lawson","year":"1987","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jss.2022.06.031_bib17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jlb.62.5.588","article-title":"Mechanism and biological significance of constitutive expression of MGSA\/GRO chemokines in malignant melanoma tumor progression","volume":"62","author":"Luan","year":"1997","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jss.2022.06.031_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jlb.67.1.53","article-title":"The tumorigenic and angiogenic effects of MGSA\/GRO proteins in melanoma","volume":"67","author":"Haghnegahdar","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jss.2022.06.031_bib19","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1158\/1078-0432.CCR-15-0244","article-title":"Differential expression of immune-regulatory genes associated with PD-L1 display in melanoma: implications for PD-1 pathway blockade","volume":"21","author":"Taube","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2022.06.031_bib20","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20160855","article-title":"An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition","volume":"214","author":"Young","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jss.2022.06.031_bib21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1189\/jlb.0408231","article-title":"The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice","volume":"84","author":"Bento","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jss.2022.06.031_bib22","doi-asserted-by":"crossref","first-page":"14428","DOI":"10.18632\/oncotarget.14803","article-title":"Ladarixin, a dual CXCR1\/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment","volume":"8","author":"Kemp","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2022.06.031_bib23","doi-asserted-by":"crossref","first-page":"83155","DOI":"10.18632\/oncotarget.17950","article-title":"HDAC inhibitors enhance the immunotherapy response of melanoma cells","volume":"8","author":"Booth","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2022.06.031_bib24","doi-asserted-by":"crossref","first-page":"31090","DOI":"10.18632\/oncotarget.25783","article-title":"C-X-C Motif Ligand 1 (CXCL1) from melanoma cells down-regulates the invasion of their metastatic melanoma cells","volume":"9","author":"Hatano","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2022.06.031_bib25","doi-asserted-by":"crossref","first-page":"619003","DOI":"10.3389\/fonc.2021.619003","article-title":"CXC chemokines as therapeutic targets and prognostic biomarkers in skin cutaneous melanoma microenvironment","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jss.2022.06.031_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/pcmr.12599","article-title":"Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells","volume":"30","author":"Flem-Karlsen","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jss.2022.06.031_bib27","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/jid.2013.114","article-title":"B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma","volume":"133","author":"Wang","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jss.2022.06.031_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2567.2009.03236.x","article-title":"Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites","volume":"130","author":"Kobori","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.jss.2022.06.031_bib29","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/eji.200839028","article-title":"B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction","volume":"39","author":"Leitner","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jss.2022.06.031_bib30","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/1078-0432.CCR-12-0715","article-title":"Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity","volume":"18","author":"Loo","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2022.06.031_bib31","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1158\/1535-7163.MCT-11-0072","article-title":"B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2\/Stat3 phosphorylation","volume":"10","author":"Liu","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jss.2022.06.031_bib32","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/ijc.26238","article-title":"B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes","volume":"130","author":"Tekle","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jss.2022.06.031_bib33","doi-asserted-by":"crossref","first-page":"53869","DOI":"10.18632\/oncotarget.10861","article-title":"c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus","volume":"7","author":"Nihal","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2022.06.031_bib34","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/ng.3382","article-title":"Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway","volume":"47","author":"Shain","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jss.2022.06.031_bib35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature12998","article-title":"The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells","volume":"507","author":"Paolino","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jss.2022.06.031_bib36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00384-014-1839-5","article-title":"Up-regulation of c-Cbl suggests its potential role as oncogene in primary colorectal cancer","volume":"29","author":"Crist\u00f3bal","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jss.2022.06.031_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1158\/1078-0432.CCR-14-0610","article-title":"Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition","volume":"21","author":"Kadera","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2022.06.031_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/cgt.2012.88","article-title":"c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4\/5","volume":"20","author":"Kim","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jss.2022.06.031_bib39","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1074\/jbc.M112.339820","article-title":"Met kinase-dependent loss of the E3 ligase Cbl in gastric cancer","volume":"287","author":"Lai","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2022.06.031_bib40","first-page":"1243","article-title":"Cbl-regulated Akt and ERK signals are involved in \u03b2-elemene-induced cell apoptosis in lung cancer cells","volume":"4","author":"Li","year":"2011","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jss.2022.06.031_bib41","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3892\/etm.2015.2283","article-title":"Cbl-b-regulated extracellular signal-regulated kinase signaling is involved in the shikonin-induced apoptosis of lung cancer cells in\u00a0vitro","volume":"9","author":"Qu","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jss.2022.06.031_bib42","doi-asserted-by":"crossref","first-page":"e8972","DOI":"10.1371\/journal.pone.0008972","article-title":"CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases","volume":"5","author":"Tan","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jss.2022.06.031_bib43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10585-018-9898-6","article-title":"Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials","volume":"35","author":"Faries","year":"2018","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.jss.2022.06.031_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2022.06.031_bib45","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/cncr.11250","article-title":"Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase\/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients","volume":"97","author":"Garbe","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2022.06.031_bib46","first-page":"2685","article-title":"Diagnostic accuracy and predictive value of the tumor-associated antigen S100 in malignant melanomas: validation by whole body FDG-PET and conventional diagnostics","volume":"19","author":"Mruck","year":"1999","journal-title":"Anticancer Res"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480422003869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480422003869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:02:37Z","timestamp":1758380557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480422003869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":46,"alternative-id":["S0022480422003869"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2022.06.031","relation":{},"ISSN":["0022-4804"],"issn-type":[{"type":"print","value":"0022-4804"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Four Immune Modulating Genes in Primary Melanoma That Predict Metastatic Potential","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2022.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}